EGAS00001002124-3-sc-20190205 - samples

ABSTRACT: Precision medicine trials in glioblastoma should be conducted at tumor recurrence. However, second surgery for recurrent GBMs is not routinely performed and therefore molecular data is predominantly derived from primary samples. This study aims to establish the frequency of driver changes at tumor recurrence.

PROVIDER: EGAD00001004593 | EGA |

REPOSITORIES: EGA